Advertisement

Topics

Nventa Biopharmaceuticals Corporation Company Profile

03:58 EDT 25th September 2017 | BioPortfolio

Nventa Biopharmaceuticals Corporation (TSX:NVN) is developing innovative therapeutics for the treatment of viral infections, with a focus on diseases caused by the human papillomavirus (HPV). Our lead therapeutic candidate is HspE7, a novel therapeutic vaccine designed for the treatment of diseases caused by the human papillomavirus (HPV), one of the most common sexually transmitted diseases in the world. An estimated 80% of sexually active men and women are infected by genital HPV at some point in their lives. Approximately 5.5 million new sexually transmitted HPV infections are reported in the U.S. each year. At least 20 million people in the U.S. are already infected. HPV infection can result in diseases including internal and external genital warts and precancerous conditions, such as cervical and anal dysplasia. Precancerous HPV-related conditions can progress into life-threatening diseases, including cervical, anal, and head and neck cancers.

Location

6055 Lusk Boulevard
San Diego
California
92121
United States of America

Contact

Phone: (858) 202-4900
Fax: (858) 450-6849
Email: dquarry@nventacorp.com


News Articles [193 Associated News Articles listed on BioPortfolio]

Critical Analysis: Keryx Biopharmaceuticals (KERX) vs. Its Peers

Keryx Biopharmaceuticals is one of 288 public companies in the "Bio Therapeutic Drugs" industry, but how does it weigh in compared to its rivals? We will compare Keryx Biopharmaceuticals to related co...

Alder BioPharmaceuticals (ALDR) versus Raptor Pharmaceutical Corp (RPTP) Head to Head Comparison

Alder BioPharmaceuticals and Raptor Pharmaceutical Corp are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recomm...

Innovate Biopharmaceuticals's Pediatric Ulcerative Colitis Drug Granted Innovate Biopharmaceuticals Orphan Designation

  Life Sciences Jobs   ...

Sienna Biopharmaceuticals nets $60mm in Nasdaq IPO

Aesthetics- and dermatology-focused Sienna Biopharmaceuticals Inc. (targeted topical delivery technology) netted $60mm through an initial public offering of 4.33mm shares at $15, the midpoint of its a...

'Small intestinal permeable peptides' improve biopharmaceuticals absorption in digestive tract

Biopharmaceuticals, medium- and high-molecular weight biologically active macromolecules, are not easily absorbed by the small intestine, the main organ responsible for gastrointestinal absorption, re...

Keryx Biopharmaceuticals, Inc. (KERX) Downgraded by ValuEngine

Several other research firms have also commented on KERX. Zacks Investment Research upgraded Keryx Biopharmaceuticals from a hold rating to a buy rating and set a $8.75 price objective for the company...

Intrinsic4D Inc. Announces Public Sale of Substantially all of the Assets of its Operating Subsidiary and Transfer to NEX

TORONTO, ONTARIO -- (Marketwired) -- 05/11/17 -- Intrinsic4D Inc. (the "Corporation") (TSX VENTURE: IFD) provides stakeholders with an update in relation to its financial status and solvency. Publi...

Keryx Biopharmaceuticals, Inc. (KERX) Shares Up 5.4%

Keryx Biopharmaceuticals, Inc. shares shot up 5.4% during mid-day trading on Friday . The company traded as high as $7.68 and last traded at $7.60, with a volume of 1,238,961 shares trading hands.

PubMed Articles [49 Associated PubMed Articles listed on BioPortfolio]

Current practice of therapeutic drug monitoring of biopharmaceuticals in psoriasis patients.

The high prevalence of psoriasis and the high spending on pharmaceuticals motivate a more evidence-based and cost-effective usage of biopharmaceuticals. A growing body of evidence exists that the impl...

Biopharmaceuticals: reference products and biosimilars to treat inflammatory diseases.

Biopharmaceuticals are primarily therapeutic proteins developed to perform specific functions by acting on the disease pathophysiology. Compared to low molecular chemically synthesized drugs, producti...

Current practice of therapeutic drug monitoring of biopharmaceuticals in spondyloarthritis.

Treatment of spondyloarthritis (SpA) has greatly improved in the biopharmaceutical era. These compounds, primarily tumor necrosis factor (TNF) inhibitors, are effective, but some patients may show poo...

Immunoassays for measuring serum concentrations of monoclonal antibodies and anti-biopharmaceutical antibodies in patients.

Monoclonal antibodies (mAbs) may be used as biopharmaceuticals to treat various diseases, ranging from oncology to inflammatory and cardiovascular affections. Trustworthy analytical methods are necess...

Current practice for therapeutic drug monitoring of biopharmaceuticals in inflammatory bowel disease.

Since the late nineties, biopharmaceuticals targeting tumor necrosis factor α have revolutionized the treatment of moderately to severely active inflammatory bowel disease. The robust efficacy witnes...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Nicotine Vaccination and Nicotinic Receptor Occupancy

This is a molecular imaging research study designed to examine how much nicotine gets into the brain before and after vaccination with NicVAX, a nicotine vaccine developed by Nabi Biopharm...

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus influenza type b (Hib) remains a serious global health threat associated with high mortality and morbidity in young children. In China, The overall impact of Hib-related infect...

Companies [353 Associated Companies listed on BioPortfolio]

Nventa Biopharmaceuticals Corporation

Nventa Biopharmaceuticals Corporation (TSX:NVN) is developing innovative therapeutics for the treatment of viral infections, with a focus on diseases caused by the human papillomavirus (HPV). Our le...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Itero Biopharmaceuticals, Inc.

Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical an...

Bechtel Group Biopharmaceuticals Production

Design, construction, and validation of facilities for production of human biopharmaceuticals utilizing either fermentation or cell culture, facilities maintenance & operation for the virtual organiza...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

More Information about "Nventa Biopharmaceuticals Corporation" on BioPortfolio

We have published hundreds of Nventa Biopharmaceuticals Corporation news stories on BioPortfolio along with dozens of Nventa Biopharmaceuticals Corporation Clinical Trials and PubMed Articles about Nventa Biopharmaceuticals Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nventa Biopharmaceuticals Corporation Companies in our database. You can also find out about relevant Nventa Biopharmaceuticals Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cervical Cancer
Cervical cancer is a malignant neoplasm of the cervix uteri or cervical area. Symptoms include vaginal bleeding, but may not present until later stages of the cancer. Cervical cancer can be treated using surgery (including local excision) in early stages...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record